At the Hid things are moving fast.
Latest news
At the Hid things are moving fast.

Latest news

All there is to know about the Hid

RA2day, November 19, 2021, Amsterdam
In the past decade, more than 25% of drug approvals were for treatment of cancer. Much can be learned from the regulatory pathways taken and regulatory tools used. Have regulatory initiatives to speed up development and authorization of cancer drugs lived up to the expectations?

Lees meer
19/10/2021

Sanquin Academy – the connecting factor in the Hid
The Sanquin Academy was launched in 2021 as an independent business unit, located in Amsterdam’s New West Health & Innovation District (HID). In this interview, founder Anouk Wagenaar talks about the goals and potential of the Sanquin Academy, as well as her motivation and ambitions for the Academy.

Lees meer
13/10/2021

More Hid coffee moments to come, after first edition yesterday
The library (next to Galerie Joghem) has been converted into a pleasant place for both Hid residents and Sanquiners. You can meet here informally or work in a nice shared space. The space is accessible to everyone all day long.

Lees meer
06/10/2021

Half a million subsidy for expansion of laboratory and office space at Hid
From 2022, the New West Health & Innovation District (Hid) in Amsterdam will provide new laboratory and office space for companies in transfusion medicine, immunology, hematology and oncology. The need for office and lab space for these types of companies is great.

Lees meer
20/09/2021

Hid resident BISC Global receives grant for further development of analysis software for immune repertoire
Hid residents talk about their projects and research results. BISC Global is a resident of the Hid. They recently received a large grant to further develop their Immune Repertory Analysis Software.

Lees meer
15/09/2021

Extraordinary developments: Blood grown to order
Blood made to order, grown from stem cells: it might sound like science fiction, but for research group leader Emile van den Akker, it’s part of his daily work schedule. His Haematopoiesis research group at Sanquin Research is exploring ways of generating blood tailored to patients for whom it is difficult to find suitable donor blood. The research group is supported by a prestigious fund from ZonMw.

Lees meer
26/07/2021

Come and work in the New West Health & Innovation District –in 2022!
The New West Health & Innovation District was officially launched in April 2021, with new residents, events, programmes and an academy. Ector Hoogstad Architecten has designed a master plan focused on creating an open and vibrant district that offers genuine opportunities for innovation. From 2023, the first phase of the master plan will be built.

Lees meer
14/07/2021

Innovative cancer immunotherapies start-up
Hid tenant Frame Therapeutics develops on a novel cancer treatment based on personalised immunotherapies. The young start-up is like a duck takes to water on the Hid campus, not least because of the presence of Sanquin’s sophisticated laboratories.

Lees meer
23/06/2021

"Sanquin is a fantastic partner to work with"
Our immune system is a wonderful thing: it consists of various defence mechanisms that keep out bacteria, viruses and other molecules foreign to the body. At Sanquin Research, located at the New West Health & Innovation District (Hid), a large group of scientists are intensively researching the immune system in order to unravel all its secrets.

Lees meer
16/06/2021

Collaboration Sanquinnovate and Thuja
Sanquinnovate is Sanquin’s technology valorization and business development arm, creating new value-adding therapeutics and diagnostics to tackle challenges in the fields of hematology, immunology and oncology. Thuja is a venture capital fund manager investing in early stage life sciences innovations with high healthcare impact potential.

Lees meer
15/06/2021

Sanquin and OLVG join forces in Amsterdam National Laboratory Centre on Hid site
Sanquin Diagnostics and OLVG Lab want to join forces in a large-scale regional laboratory that the government and the people can quickly rely on in the event of future virus crises.

Lees meer
10/06/2021

Sanquin and OLVG join forces in Amsterdam National Laboratory Centre on Hid site
Sanquin Diagnostics and OLVG Lab want to join forces in a large-scale regional laboratory that the government and the people can quickly rely on in the event of future virus crises.

Lees meer
12/05/2021

New West Health & Innovation District launched in Amsterdam
This week, the New West Health & Innovation District (Hid) in Amsterdam is launched. On this knowledge-intensive square kilometer in Amsterdam New-West, Sanquin is creating a campus that will house international scientists, start-ups and scale-ups and established companies in the field of oncology, immunology and hematology.

Lees meer
21/04/2021

Rare coagulation diseases
Sanquin is working with the Netherlands Institute for Neuro Science and the Amsterdam-based start-up SanaGen on the development of gene therapy for the effective treatment of these diseases.

Lees meer
25/11/2020

Working in the post-corona era
What are work environments like in the post-corona era? Architect Joost Ector: "Where people come together, ideas are born. A campus stimulates precisely this casual meeting, this informal exchange. "

Lees meer
24/11/2020

Antibodies for treatment COVID-19
Hid resident Prothya Biosolutions released the first batch in October 2020. In only three months, the convalescent plasma (with antibodies against COVID-19) collected from ex-corona patients was tested and processed.

Lees meer
05/11/2020

International investors for Prothya Biosolutions
A group of international investors invests heavily in Prothya Biosolutions and its associated company Plasma Industries Belgium (PIBe). This will make growth and further market expansion possible.

Lees meer
05/11/2020

Iron storage
Blood donors who get more iron from meat or fish (heme iron) may be better capable of maintaining their iron storage, according to Tiffany Timmer, researcher at Sanquin Research.

Lees meer
05/10/2020